|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 35/34 | (2015.01) |
| A61L 27/38 | (2006.01) | ||
| A61P 9/04 | (2006.01) | ||
| C12N 5/077 | (2010.01) |
| (11) | Number of the document | 3402543 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17738878.2 |
| Date of filing the European patent application | 2017-01-11 | |
| (97) | Date of publication of the European application | 2018-11-21 |
| (45) | Date of publication and mention of the grant of the patent | 2021-09-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/013054 |
| Date | 2017-01-11 |
| (87) | Number | WO 2017/123662 |
| Date | 2017-07-20 |
| (30) | Number | Date | Country code |
| 201662277359 P | 2016-01-11 | US |
| (72) |
MARBAN, Eduardo , US
GALLET, Romain , FR
|
| (73) |
Cedars-Sinai Medical Center ,
8700 Beverly Boulevard, Los Angeles, CA 90048,
US
|
| (54) | CARDIOSPHERE-DERIVED CELLS AND EXOSOMES SECRETED BY SUCH CELLS IN THE TREATMENT OF HEART FAILURE WITH PRESERVED EJECTION FRACTION |
| CARDIOSPHERE-DERIVED CELLS AND EXOSOMES SECRETED BY SUCH CELLS IN THE TREATMENT OF HEART FAILURE WITH PRESERVED EJECTION FRACTION |